Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,031 total articles
Wrap Technologies has been chosen by WOFT Charities to provide training services for a newly funded $475,000 Teacher Safety Training Program in Florida. This program aims to enhance situational awareness and safety skills among teachers and school personnel, expanding Wrap’s public safety training expertise beyond law enforcement into education.
BridgeBio Pharma announced the pricing of a secondary offering of 5 million shares of common stock by selling shareholder KKR Genetic Disorder L.P. The company itself is not selling shares and will not receive proceeds from this transaction. The offering aims to diversify and evolve BridgeBio's institutional shareholder base toward long-term, high-…
Helus Pharma reported Q1 Fiscal 2027 results highlighting completion of enrollment in its Phase 3 APPROACH study for HLP003 in Major Depressive Disorder with top-line data expected in Q4 2026. The company appointed Michael Halstead as CEO to lead late-stage development and commercialization efforts. Its Phase 2 candidate HLP004 showed meaningful im…
Outlook Therapeutics announced its Q3 fiscal 2026 financial results and detailed progress toward the U.S. commercial launch of LYTENAVA™, the only FDA-approved ophthalmic bevacizumab for wet age-related macular degeneration (wet AMD). The company aims to launch LYTENAVA in the U.S. by the end of 2026 and projects potential annual sales exceeding $5…
JOYY Inc., a global technology company listed on NASDAQ, announced it will release its second quarter 2026 financial results after U.S. market close on August 25, 2026. The company's management will host an earnings conference call to discuss the results on the same day, providing a webcast and replay access for investors and analysts.
Beyond Meat, Inc. has completed a 1-for-30 reverse stock split effective August 13, 2026, reducing the number of outstanding shares and authorized shares to help the company meet Nasdaq's minimum bid price requirement. The adjusted shares will begin trading on August 14, 2026 under the ticker BYND. The reverse split proportionately adjusts conversi…
Tvardi Therapeutics announced its second quarter 2026 financial results and provided a business update highlighting topline healthy volunteer results for its next-generation STAT3 inhibitor, TTI-109, confirming the prodrug design, improved tolerability, and reductions in immune cell populations relevant to ulcerative colitis (UC). The company selec…
Neumora Therapeutics reported its second quarter 2026 financial results, highlighting progress in its drug pipeline including favorable preclinical data for NMRA-215 with planned IND submission and Phase 1 study initiation by end of 2026. NMRA-511 and NMRA-898 programs targeting Alzheimer's agitation and schizophrenia are progressing towards clinic…
Teamshares announced Q2 2026 results showing 20% revenue growth to $148.7 million, net income of $9.5 million, and a 166% increase in Adjusted EBITDA year-over-year. The company reaffirmed its 2026 full-year outlook with a $40 million EBITDA acquisition target, underpinned by a strong pipeline including $30 million annual EBITDA under letters of in…
Adlai Nortye Ltd. reported strong operational progress with ongoing enrollment in global Phase I trials for its pan-RAS(ON) inhibitor AN9025 and regulatory approval for Phase I trial of AN4035 ADC. The company raised a total of $290 million in equity financing in early 2026, significantly boosting its cash reserves. Financial results show increased…
Fate Therapeutics has initiated the RECLAIM-LN Phase 2 clinical trial of its off-the-shelf FT819 CAR T-cell therapy in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE) with lupus nephritis. The trial, supported by RMAT designation and FDA pilot programs, aims to enroll about 53 patients and evaluate the therapy's safet…
Aurora Mobile Limited (NASDAQ: JG) announced a three-year Memorandum of Understanding with Exabytes, a leading AI-driven digital solutions provider in Southeast Asia, to jointly develop and deploy AI-powered customer engagement solutions. The partnership aims to integrate Aurora Mobile’s AI-first platforms, EngageLab and GPTBots.ai, with Exabytes’ …
Quantum BioPharma Ltd. reported a stronger liquidity position with cash and equivalents nearly doubling to $3.65 million and total assets increasing to $9.5 million as of mid-2026. The company reduced operating expenses by over 50% year-over-year while extending its cash runway to at least October 2027. Importantly, the FDA approved Quantum's Inves…
PowerCompute, a Nasdaq-listed Bitcoin mining and treasury company, reported Q2 2026 revenue growth of 9.8% year-over-year driven by increased Bitcoin mining production despite lower Bitcoin prices. The company expanded strategically into high-performance computing (HPC) and AI infrastructure leveraging its power assets and entered into a GPU comput…
Brookfield Business Corporation has announced the renewal of its normal course issuer bid, authorizing the company to repurchase up to 10,272,100 Class A subordinate voting shares, representing 5% of outstanding shares. The buyback, effective from August 19, 2026, to August 18, 2027, aims to invest in shares that trade below their perceived intrins…
Rein Therapeutics reported strong progress in its Phase 2 RENEW trial of LTI-03 for idiopathic pulmonary fibrosis (IPF), surpassing 25% enrollment ahead of schedule and expecting interim data in H2 2026. The company also completed an oversubscribed $57.5 million public offering, strengthening its financial position to fund ongoing operations throug…
UTStarcom Holdings Corp. reported unaudited financial results for the first half of 2026 showing a 26.1% decline in revenue to $3.4 million and an increased net loss of $5.1 million compared to $3.7 million in the prior year period. The company is advancing its Optical Circuit Switching (OCS) technology for AI data center networking and continues t…
Diginex Limited announced an amended agreement for the acquisition of Resulticks Global Companies Pte. Limited, combining Diginex's ESG and sustainability compliance solutions with Resulticks' AI-powered customer engagement technology. The all-share deal values Resulticks at $1.05 billion, with its shareholders becoming majority owners of the combi…
Kodiak AI, a Nasdaq-listed leader in autonomous vehicle technology, announced it received a drivered testing permit from the California DMV under new regulations allowing heavy-duty autonomous vehicles to test on public roads. This permit enables Kodiak to begin scaling its autonomous trucking operations across the U.S., starting with California, m…
Super Hi International Holding Ltd., operating Haidilao hot pot restaurants globally, announced it will report its unaudited financial results for Q2 2026 before US market open on August 26, 2026. The company will host a bilingual earnings call, providing insights into its performance and operations across 127 international locations as of March 20…
SFL Corporation Ltd., a maritime industry company listed on the NYSE, will release its preliminary financial results for Q2 2026 on August 26, 2026, followed by a webcast and conference call for investors and analysts. The company has a diversified fleet and a history of consistent quarterly dividends. The announcement includes forward-looking stat…
Diversified Energy Company addresses recent media speculation about a potential transaction involving the company. The firm confirms ongoing preliminary discussions regarding a possible acquisition of Birch Resources. No agreement has been reached and there is no certainty that a transaction will proceed. The company emphasizes its disciplined acqu…
Western Union and Intermex provided an update on Western Union's pending acquisition of Intermex, highlighting recent regulatory developments. While the New York State Department of Financial Services approved the transaction with commitments, the California Department of Financial Protection and Innovation has suspended its prior approval to condu…
Zentalis Pharmaceuticals announced an underwritten public offering of 23 million shares at $3.50 each, expected to raise approximately $80.5 million before expenses. The proceeds will support ongoing clinical trials, preclinical studies, regulatory activities, manufacturing, and other corporate purposes primarily related to their investigational WE…
RCM Technologies, Inc. announced its financial results for the second quarter of 2026, revealing a 20% increase in revenue to $93.8 million and an 18.8% rise in adjusted net income per diluted share compared to the prior year period. The company experienced growth across its Specialty Healthcare, Engineering, and Life Sciences segments, supported b…
